Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 14, 2023

SELL
$126.46 - $235.05 $302,365 - $562,004
-2,391 Closed
0 $0
Q4 2021

Nov 14, 2023

BUY
$225.82 - $368.51 $539,935 - $881,107
2,391 New
2,391 $607 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Silicon Valley Community Foundation Portfolio

Follow Silicon Valley Community Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Community Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Community Foundation with notifications on news.